Plasma adiponectin levels in post-menopausal women receiving hormone replacement therapy

Journal of International Medical Research

Volumn 32, Issue 6, 2004, Pages 639-645

  Sumino, H ^a   Takahashi, T ^b   Itoh, T ^b   Kusaka, K ^b   Yamakawa, J ^b   Ichikawa, S ^c   Kurabayashi, M ^a   Kanda, T ^b  

^a GUNMA UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c Cardiovascular Hospital of Central Japan   (Japan)

Author keywords

Adiponectin; Hormone replacement therapy; Post menopausal women

Indexed keywords

ADIPONECTIN; CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE TIME EFFECT RELATION; FEMALE; HOMEOSTASIS; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 9444269223     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000403200609     Document Type: Article

References (15)

1. Wenger NK, Speroff L, Packard B: Cardiovascular health and disease in women. N Engl J Med 1993; 329: 247-256.
2. Shlipak MG, Chaput LA, Vittinghoff E, Lin F, Bittner V, Knopp RH, et al. for the Heart and Estrogen/progestin Replacement Study Investigators: Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS). Am Heart J 2003; 146: 870-875.
3. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286-289.
4. Arita Y, Kihara S, Ouchi N, Takahashi M, Maedo K, Miyagawa J, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
5. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476.
6. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296-1301.
7. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057-1063.
8. Matsubara M, Maruoka S, Katayose S: Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147: 173-180.
9. Tuominen JA, Ebeling P, Laquier FW, Heiman ML, Stephens T, Koivisto VA: Serum leptin concentration and fuel homeostasis in healthy man. Eur J Clin Invest 1997; 27: 206-211.
10. Bai Y, Zhang S, Kim KS, Lee JK, Kim KH: Obese gene expression alters the ability of 30A5 pre-adipocytes to respond to lipogenic hormones. J Biol Chem 1996; 271: 13939-13942.
11. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, et al: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci 2002; 103: 137-141.
12. Higashi Y, Sanada M, Sasaki S, Nakagawa K, Goto C, Matsuura H, et al: Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension 2001; 37: 651-657.
13. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, et al: Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121: 936-941.
14. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III: Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90: 786-791.
15. Barrett-Connor E, Wingard DL, Criqui MH: Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited. JAMA 1989; 261: 2095-2100.